More Than Two-Thirds of U.S. Counties Do Not Have a Gastroenterologist
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 21, 2025 -- About 69 percent of U.S. counties do not have a gastroenterologist, according to a research letter published online Feb. 6 in Gastroenterology.
Xiaohan Ying, M.D., from Weill Cornell Medicine in New York City, and colleagues examined geographic disparities in access to gastroenterologists in the United States in a cross-sectional study using physician workforce data from 2020 to 2021 and county demographic data from the 2020 U.S. Census.
The researchers found that 69.3 percent of the 3,149 U.S. counties analyzed, corresponding to 49.4 million individuals, did not have any gastroenterologists; 16.8 and 5.6 percent had ≤5 and 20 gastroenterologists, respectively. Thirty-nine percent of the 1,167 metropolitan counties had no gastroenterologists compared with 87.4 percent of 1,975 nonmetropolitan counties. Compared with counties with gastroenterologists, those without gastroenterologists were more likely to be nonmetropolitan (79.1 versus 25.8 percent), have older populations (median age, 43 versus 40 years), have a lower rate of non-White (23.4 versus 32.3 percent) and foreign-born individuals (2.0 versus 5.4 percent), have lower median household income ($53,826 versus $62,739), and have fewer uninsured individuals (10.2 versus 12.2 percent). Overall, 45 percent of the population lived within 10 miles of the nearest gastroenterologist, and 14 and 2 percent lived more than 25 and more than 50 miles away, respectively.
"Although there is adequate access to gastroenterologists on a national level generally, with >80 percent of the population in the United States living within 25 miles of the nearest gastroenterologist, further efforts are needed to expand access to gastroenterologists and improve equity," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-23 00:00
Read more

- FDA Approves Ospomyv (denosumab-dssb), a Biosimilar to Prolia
- Decline in BMI, Waist Circumference Seen in Decade Before Dementia
- Black Maternal Deaths Remain High Despite Overall Decline In U.S.
- Abortion Pill Alternative Found in Morning-After Pill
- Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
- Boston Surgeons Successfully Transplant Pig Kidney in Fourth Patient
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions